Thalidomide in multiple myeloma [2] (multiple letters)

New England Journal of Medicine

Volumn 342, Issue 13, 2000, Pages 975-976

  Kishi, Y ^a   Oki, Y ^a   Machida, U ^a   Barlogie, B ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

THALIDOMIDE;

ANTINEOPLASTIC ACTIVITY; DOSE RESPONSE; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; HUMAN; LETTER; MULTIPLE MYELOMA; PRIORITY JOURNAL;

ANGIOGENESIS INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MULTIPLE MYELOMA; NEOPLASM STAGING; PROGNOSIS; SURVIVAL ANALYSIS; THALIDOMIDE;

EID: 0034732149     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200003303421313     Document Type: Letter

References (0)